Welcome Guest!  Login | Register | Help | Survey
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly  Settings
GHDX [NASD]
Genomic Health Inc.
Healthcare - Medical Laboratories & Research - USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.33 Insider Own10.66% Shs Outstand28.61M Perf Week1.84%
Market Cap491.52M Forward P/E49.09 EPS next Y0.35 Insider Trans0.99% Shs Float25.56M Perf Month-2.11%
Income-9.41M PEG- EPS next Q-0.03 Inst Own65.45% Short Float12.84% Perf Quarter-14.44%
Sales149.55M P/S3.29 EPS this Y42.05% Inst Trans4.17% Short Ratio19.00 Perf Half Y-11.90%
Book/sh2.39 P/B7.19 EPS next Y600.00% ROA-10.77% Target Price21.10 Perf Year-20.06%
Cash/sh2.01 P/C8.56 EPS next 5Y15.00% ROE-13.97% 52W Range15.81 - 27.22 Perf YTD-12.17%
Dividend- P/FCF- EPS past 5Y0.00% ROI-13.57% 52W High-36.88% Beta0.72
Dividend %- Quick Ratio4.02 Sales past 5Y240.44% Gross Margin78.23% 52W Low8.67% ATR0.60
Employees387 Current Ratio4.02 Sales Q/Q26.73% Oper. Margin-6.29% RSI (14)43.25 Volatility3.52% 3.15%
OptionableYes Debt/Eq0.00 EPS Q/Q85.52% Profit Margin-6.29% Rel Volume0.61 Prev Close16.94
ShortableYes LT Debt/Eq0.00 EarningsFeb 03 AMC Payout- Avg Volume172.76K Price17.18
Recom2.50 SMA201.09% SMA50-8.63% SMA200-9.97% Volume105,226 Change1.42%
22-Jan-10Upgrade Piper Jaffray Neutral → Overweight
21-Jan-10Initiated Jefferies & Co Hold $18
08-Jan-10Initiated ThinkEquity Buy
11-Jun-09Upgrade Thomas Weisel Market Weight → Overweight $23
08-Oct-08Initiated Oppenheimer Perform
08-Sep-08Downgrade Canaccord Adams Buy → Hold $24 → $22
06-Aug-08Reiterated JMP Securities Mkt Outperform $32 → $35
07-May-08Reiterated RBC Capital Mkts Outperform $27 → $26
07-May-08Reiterated Canaccord Adams Buy $22 → $24
12-Mar-08Downgrade JP Morgan Overweight → Neutral
07-Feb-08Upgrade RBC Capital Mkts Sector Perform → Outperform
06-Feb-08Upgrade Cantor Fitzgerald Hold → Buy $27 → $34
29-Jan-08Initiated Canaccord Adams Buy $27
17-Jan-08Downgrade Leerink Swann Outperform → Mkt Perform
21-Dec-07Upgrade RBC Capital Mkts Underperform → Sector Perform
01-Nov-07Downgrade Cantor Fitzgerald Buy → Hold $27
31-Oct-07Reiterated JMP Securities Mkt Outperform $31 → $32
09-Oct-07Reiterated Lehman Brothers Equal-weight $26 → $19
07-Aug-07Reiterated RBC Capital Mkts Underperform $17 → $20
19-Jul-07Reiterated JMP Securities Mkt Outperform $26 → $31
04-Feb-10 09:24AM  New Star Analyst Rankings for Genomic Health, Inc. StarMine
03-Feb-10 04:10PM  GENOMIC HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events EDGAR Online
04:06PM  InPlay: Genomic Health beats by $0.05, misses on revs; guides FY10 revs Briefing.com
04:02PM  Genomic Health Announces Year-End 2009 Financial Results PR Newswire
07:07AM  Q4 2009 Genomic Health, Inc. Earnings Release - After Market Close CCBN
27-Jan-10 08:00AM  Genomic Health to Announce Fourth Quarter and Year-End 2009 Financial Results and Host Conference Call on Wednesday, February 3 PR Newswire
25-Jan-10 08:29AM  5 Diagnostics Stocks Get 2010 Buy Rating From Natixis Bleichroeder Expert Industry Analyst Wall Street Transcript
24-Jan-10 01:00PM  Gene discovery may help guide breast cancer care at Reuters
22-Jan-10 03:58PM  Good News from Genomic Health Zacks.com
07:44AM  Genomic Health upgraded by Piper Jaffray Briefing.com
21-Jan-10 08:00AM  Genomic Health Announces Worldwide Availability of the Oncotype DX(R) Colon Cancer Test PR Newswire
12-Jan-10 08:00AM  Genomic Health Announces Publication of Data Demonstrating that the Oncotype DX(R) Breast Cancer Test Significantly Influences Breast Cancer Treatment Decisions, While Increasing Physician Confidence and Patient Satisfaction PR Newswire
08-Jan-10 10:59AM  Genomic Health Provides Guidance Zacks.com -6.90%
07-Jan-10 06:34PM  Genomic Health 4Q revenue hurt by payment delays AP
05:10PM  Genomic Health Announces Preliminary Q4 and 2009 Revenue PR Newswire
04-Jan-10 08:00AM  Genomic Health to Present at J.P. Morgan Healthcare Conference PR Newswire
15-Dec-09 08:00AM  Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations PR Newswire
14-Dec-09 11:13AM  Recent U.S. Health Care Legislation Benefits Certain Stocks The Most: Which Ones Are Best Positioned To Reap The Benefits? Wall Street Transcript
11-Dec-09 09:45AM  GHDX Reveals Oncotype DX Data Zacks.com
08:00AM  Genomic Health Announces Results of Clinical Survey Showing Use of Oncotype DX(R) Changes Treatment Recommendations for Women With Lymph Node-Positive Breast Cancer, Leading to Overall Reduction in Chemotherapy PR Newswire
10-Dec-09 06:54PM  Chemotherapy boosts breast cancer survival -study at Reuters
06:30PM  Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy PR Newswire
11:41AM  Medicare Advantage Rates Paid By U.S. Govt. Down 9% In 2010 - Resulting In Heavy Financial Losses, According To Senior Health Care Analyst Wall Street Transcript
04-Dec-09 08:00AM  Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium PR Newswire
24-Nov-09 08:00AM  Genomic Health to Present at Piper Jaffray Health Care Conference PR Newswire
20-Nov-09 02:50PM  4-Star Stocks on the Upswing at Motley Fool
13-Nov-09 09:05AM  GENOMIC HEALTH INC Financials EDGAR Online Financials
09-Nov-09 09:49PM  Mad Mail: Buy the Berkshire Hathaway Split? at CNBC
06:50PM  [video] Homework at CNBC
05:17PM  GENOMIC HEALTH INC Files SEC form 10-Q, Quarterly Report EDGAR Online
06-Nov-09 10:29AM  Genomic Health Q3 Loss Narrows Zacks.com
04-Nov-09 04:30PM  GENOMIC HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:02PM  Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress PR Newswire
07:07AM  Q3 2009 Genomic Health, Inc. Earnings Release - After Market Close CCBN
30-Oct-09 09:17AM  Zacks Bull and Bear of the Day Highlights: CarMax, Genomic Health Inc., J.C. Penney, Macy's and Bank of America Zacks.com
01:00AM  Genomic Health, Inc. (GHDX) Zacks.com
28-Oct-09 08:00AM  Genomic Health to Announce Third Quarter 2009 Financial Results and Host Conference Call on Wednesday, November 4, 2009 PR Newswire
26-Oct-09 04:42PM  Risks to personalized medicine seen in U.S. reform at Reuters
23-Oct-09 08:00AM  Genomic Health Announces Analyst Day Webcast Presentation to be Held on November 12, 2009 PR Newswire
13-Oct-09 08:31AM  Results Reveal Oncotype DX Utility Zacks.com
09-Oct-09 08:00AM  Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients PR Newswire
08-Oct-09 11:00AM  Breastcancer.org Joins My Breast Cancer Coach to Provide Newly Diagnosed Patients With Online Personalized Treatment Information Marketwire
06-Oct-09 08:00AM  Genomic Health to Present Studies at the American Society of Clinical Oncology 2009 Breast Cancer Symposium PR Newswire
30-Sep-09 08:00AM  Genomic Health to Present at the JMP Securities Healthcare Focus Conference PR Newswire
22-Sep-09 03:00AM  Genomic Health Confirms Consistent Distribution of Oncotype DX(R) Recurrence Score(R) Across European, Middle Eastern and U.S. Patient Populations Marketwire
18-Sep-09 02:36PM  4-Star Stocks on the Upswing at Motley Fool
15-Sep-09 04:37PM  Oncogene Testing Patents Key In Evaluating Stock Picks In Medical Research Sector According To Industry Expert Wall Street Transcript
03:09PM  Arrowhead Research Corp. CEO and President Interview: Christopher Anzalone Wall Street Transcript
04-Sep-09 11:00AM  Good News for Genomic Health Zacks.com
03-Sep-09 04:45PM  Oncology Surgeons Expedite Breast Cancer Treatment With Use of Oncotype DX(R) at Surgery or Biopsy Marketwire
08:00AM  Genomic Health to Present at Two Upcoming Investor Conferences PR Newswire
22-Aug-09 07:07AM  [$$] 13D Filings at Barron's Online
18-Aug-09 10:45AM  Insider Buys $5M Worth of Americredit TheStreet.com
09:53AM  4-Star Stocks Poised to Pop: Genomic at Motley Fool
12-Aug-09 01:05PM  Pacific Biosciences raises $68 million at bizjournals.com
07-Aug-09 04:31PM  GENOMIC HEALTH INC Files SEC form 10-Q, Quarterly Report EDGAR Online +6.56%
06-Aug-09 02:41PM  4-Star Stocks on the Upswing at Motley Fool
08:00AM  Genomic Health to Present at Canaccord Adams 29th Annual Global Growth Conference PR Newswire
04-Aug-09 10:05PM  Genomic Health, Inc. Q2 2009 Earnings Call Transcript at Seeking Alpha
04:17PM  GENOMIC HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:05PM  Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress PR Newswire
07:07AM  Q2 2009 Genomic Health, Inc. Earnings Release - After Market Close CCBN
31-Jul-09 03:00PM  Genomic Health Delivers Online Perspective Marketwire
29-Jul-09 02:55PM  Genomic Health: Q2 Earnings Preview Zacks.com
28-Jul-09 08:00AM  Genomic Health to Announce Second Quarter 2009 Financial Results and Host Conference Call on Tuesday, August 4, 2009 PR Newswire
14-Jul-09 05:57PM  Seracare HPV Genotype Performance Panel Distinguishes HPV16 and HPV18 Subtypes Giving Diagnostic Results for 70% of Cervical Cancers Wall Street Transcript
26-Jun-09 06:23AM  Genomic Health Inc. Needs Label Expansion at Seeking Alpha
03:00AM  Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer PR Newswire
25-Jun-09 04:34PM  GHDX Needs Label Expansion Zacks.com
11-Jun-09 10:50AM  Genomic Health shares rise on analyst upgrade AP
10-Jun-09 05:21PM  GENOMIC HEALTH INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
29-May-09 08:00AM  Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women PR Newswire
28-May-09 06:02PM  Biotech Breakthrough In Cancer at CNBC
05:25PM  [video] Another Day, Another Biotech Deal at CNBC
09:00AM  Oncotype DX(R) Guides Individualized Treatment Decisions for More Than 100,000 Breast Cancer Patients Worldwide Marketwire
08:30AM  Should You Buy It? Pharmaceutical Product Development RealMoney by TheStreet.com
21-May-09 08:00AM  Genomic Health to Present Multiple New Studies at the American Society of Clinical Oncology Annual Meeting PR Newswire
20-May-09 02:53PM  7 Stocks Attracting Top Investors at Motley Fool
04:20AM  Saks Incorporated: Peter Schoenfeld Calls for Changes at Seeking Alpha
15-May-09 03:46PM  Early Winners and Losers in an Avalanche of ASCO Data at The Wall Street Journal Online
14-May-09 06:12PM  Test may help predict colon cancer recurrence risk AP
06:01PM  Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients PR Newswire
06:00PM  Gene test predicts risk of colon cancer return at Reuters
05:58PM  Expect Big Pharma Moves Friday at CNBC
13-May-09 12:13PM  7 Stocks Attracting Top Investors at Motley Fool
08:00AM  Genomic Health to Present at JMP Securities Research Conference PR Newswire
12-May-09 09:26AM  Valueact Buys $31.5M Worth of Valeant at TheStreet.com
11-May-09 05:07PM  GENOMIC HEALTH INC Files SEC form 10-Q, Quarterly Report EDGAR Online
06-May-09 03:08PM  Earnings roundup: Garmin, Marsh & McLennan AP -18.09%
12:44PM  Genomic Health shares fall, 1st qtr meets forecast AP
05-May-09 05:05PM  Breast cancer test helps Genomic Health cut Q1 loss at bizjournals.com
04:04PM  GENOMIC HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:02PM  Genomic Health Announces First Quarter 2009 Financial Results and Business Progress PR Newswire
07:07AM  Q1 2009 Genomic Health, Inc. Earnings Release - After Market Close CCBN
28-Apr-09 08:00AM  Genomic Health to Announce First Quarter 2009 Financial Results and Host Conference Call on Tuesday, May 5, 2009 PR Newswire
20-Apr-09 08:00AM  Genomic Health Announces Study Confirming Prognostic Value of Oncotype DX(R) Recurrence Score(R) Result in Japanese Breast Cancer Patients PR Newswire
15-Apr-09 01:48PM  Genomic's Mixed Study Results Zacks.com -12.21%
14-Apr-09 05:02PM  UPDATE - Genomic Health colon cancer test meets main trial goal at Reuters
05:01PM  Genomic Health says colon cancer test met goal AP
04:18PM  GENOMIC HEALTH INC Files SEC form 8-K, Other Events EDGAR Online
Genomic Health, Inc. operates as a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. The company launched the Oncotype DX breast cancer test, which has been shown to predict the likelihood of chemotherapy benefit, as well as recurrence in early-stage breast cancer in 2004. In addition to its adopted Oncotype DX breast cancer test, Genomic Health is preparing to launch its Oncotype DX colon cancer test in early 2010. The company was founded in 2000 and is based in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cole G BradleyCOO & CFOJan 12Option Exercise1.335,0006,6506,000Jan 14 07:23 PM
Cole G BradleyCOO & CFOJan 12Sale17.255,00086,2501,000Jan 14 07:23 PM
Baker JoffreChief Scientific OfficerJan 11Sale17.474,62980,864150,120Jan 13 05:52 PM
Shak StevenChief Medical OfficerDec 21Sale20.125,000100,623388,278Dec 21 08:01 PM
Popovits Kimberly JPresident and CEODec 15Sale20.395,000101,950313,506Dec 16 05:11 PM
Cole G BradleyCOO & CFODec 14Sale20.422,00040,8431,000Dec 15 06:19 PM
Scott Randal WExecutive ChairmanDec 11Sale20.226,000121,2921,880,646Dec 14 06:19 PM
Scott Randal WExecutive ChairmanDec 10Sale20.276,000121,6461,886,646Dec 14 06:19 PM
Baker JoffreChief Scientific OfficerDec 08Sale20.264,62993,806154,749Dec 09 08:27 PM
Popovits Kimberly JPresident and CEONov 17Sale19.1915,000287,906318,506Nov 17 07:16 PM
Popovits Kimberly JPresident and CEONov 16Sale19.265,00096,301333,506Nov 17 07:16 PM
Cole G BradleyCOO & CFONov 12Option Exercise1.336658843,665Nov 13 08:00 PM
Cole G BradleyCOO & CFONov 12Sale20.0466513,3233,000Nov 13 08:00 PM
Scott Randal WExecutive ChairmanNov 11Sale19.986,000119,8921,892,646Nov 12 01:09 PM
Scott Randal WExecutive ChairmanNov 10Sale20.006,000120,0261,898,646Nov 12 01:09 PM
Baker JoffreChief Scientific OfficerNov 10Sale20.004,62992,568159,378Nov 12 01:00 PM
Shak StevenChief Medical OfficerOct 20Sale20.655,000103,230393,278Oct 21 05:03 PM
Popovits Kimberly JPresident and CEOOct 15Sale20.425,000102,117338,506Oct 15 05:55 PM
Scott Randal WExecutive ChairmanOct 13Sale20.366,000122,1601,904,646Oct 14 09:49 PM
Scott Randal WExecutive ChairmanOct 12Sale20.966,000125,7601,910,646Oct 14 09:49 PM
Baker JoffreChief Scientific OfficerOct 07Sale21.174,62997,984164,007Oct 07 09:38 PM
Shak StevenChief Medical OfficerSep 22Sale21.135,000105,670398,278Sep 24 07:50 PM
Popovits Kimberly JPresident and CEOSep 15Sale20.735,000103,632343,506Sep 16 12:52 PM
Scott Randal WExecutive ChairmanSep 11Sale20.636,000123,7801,916,646Sep 14 08:49 PM
Scott Randal WExecutive ChairmanSep 10Sale20.726,000124,3161,922,646Sep 14 08:49 PM
Baker JoffreChief Scientific OfficerSep 04Sale20.124,62993,144168,636Sep 09 04:42 PM
Shak StevenChief Medical OfficerAug 25Sale20.775,000103,850403,278Aug 27 05:41 PM
Baker Biotech Capital (GP), LLDirectorAug 17Buy19.603436,7231,253,653Aug 17 04:08 PM
Baker Brothers Life Sciences CDirectorAug 17Buy19.601,96238,4553,826,820Aug 17 04:12 PM
Baker Bros. Capital (GP), LLCDirectorAug 17Buy19.60120194,184Aug 17 04:10 PM
14159 capital (GP), LLCDirectorAug 17Buy19.60541,058103,607Aug 17 04:14 PM
Popovits Kimberly JPresident and CEOAug 17Sale19.535,00097,659348,506Aug 18 07:02 PM
Cole G BradleyCOO & CFOAug 13Option Exercise1.335,0006,6508,000Aug 17 02:37 PM
Baker Biotech Capital (GP), LLDirectorAug 13Buy19.9911,314226,1621,253,310Aug 17 04:08 PM
Baker Bros. Capital (GP), LLCDirectorAug 13Buy19.9933660194,183Aug 17 04:10 PM
Baker Brothers Life Sciences CDirectorAug 13Buy19.9964,6681,292,6873,824,858Aug 17 04:12 PM
14159 capital (GP), LLCDirectorAug 13Buy19.991,78535,681103,553Aug 17 04:14 PM
Cole G BradleyCOO & CFOAug 13Sale20.005,000100,0003,000Aug 17 02:37 PM
Baker Biotech Capital (GP), LLDirectorAug 12Buy19.704,69092,3781,241,996Aug 12 04:40 PM
Baker Bros. Capital (GP), LLCDirectorAug 12Buy19.7014276194,150Aug 12 04:38 PM
Baker Brothers Life Sciences CDirectorAug 12Buy19.7026,808528,0343,760,190Aug 12 04:37 PM
14159 capital (GP), LLCDirectorAug 12Buy19.7074014,576101,768Aug 12 04:36 PM
14159 capital (GP), LLCDirectorAug 11Buy19.361,18923,024101,028Aug 12 04:36 PM
Baker Brothers Life Sciences CDirectorAug 11Buy19.3643,012832,9073,733,382Aug 12 04:37 PM
Baker Bros. Capital (GP), LLCDirectorAug 11Buy19.3621407194,136Aug 12 04:38 PM
Baker Biotech Capital (GP), LLDirectorAug 11Buy19.367,525145,7181,237,306Aug 12 04:40 PM
Scott Randal WExecutive ChairmanAug 11Sale19.386,000116,2701,928,646Aug 11 07:19 PM
Baker Bros. Capital (GP), LLCDirectorAug 10Buy19.4910195194,115Aug 12 04:38 PM
Baker Brothers Life Sciences CDirectorAug 10Buy19.4920,934408,0363,690,370Aug 12 04:37 PM
14159 capital (GP), LLCDirectorAug 10Buy19.4957911,28699,839Aug 12 04:36 PM
Baker Biotech Capital (GP), LLDirectorAug 10Buy19.493,66271,3781,229,781Aug 12 04:40 PM
Scott Randal WExecutive ChairmanAug 10Sale19.456,000116,7251,934,646Aug 11 07:19 PM
Baker JoffreChief Scientific OfficerAug 10Sale19.484,62990,182173,265Aug 11 07:16 PM
Baker JoffreChief Scientific OfficerJul 08Sale16.014,62974,114177,894Jul 09 06:45 PM
Scott Randal WExecutive ChairmanJun 11Sale18.276,000109,6201,940,646Jun 15 02:10 PM
Baker JoffreChief Scientific OfficerJun 08Sale17.694,62981,875182,523Jun 10 06:07 PM
Shak StevenChief Medical OfficerMay 26Sale19.005,00095,000408,278May 28 01:35 PM
Baker Bros. Capital (GP), LLCDirectorMay 21Buy17.82353194,105May 22 04:16 PM
Baker Brothers Life Sciences CDirectorMay 21Buy17.824,43779,0873,669,436May 22 04:18 PM
Baker / Tisch Capital (GP), LLDirectorMay 21Buy17.8210178194,161May 22 04:29 PM
14159 capital (GP), LLCDirectorMay 21Buy17.821242,21099,260May 22 04:32 PM
14159 capital (GP), LLCDirectorMay 20Buy17.9998417,69899,136May 22 04:32 PM
Baker / Tisch Capital (GP), LLDirectorMay 20Buy17.99801,439194,151May 22 04:29 PM
Baker Brothers Life Sciences CDirectorMay 20Buy17.9935,341635,6373,664,999May 22 04:18 PM
Baker Bros. Capital (GP), LLCDirectorMay 20Buy17.9922396194,102May 22 04:16 PM
Popovits Kimberly JPresident and CEOMay 15Sale20.125,000100,600353,506May 18 08:58 PM
Scott Randal WExecutive ChairmanMay 12Sale19.416,000116,4811,946,646May 12 08:24 PM
Baker Bros. Capital (GP), LLCDirectorMay 11Buy19.4833643194,080May 11 05:44 PM
Baker / Tisch Capital (GP), LLDirectorMay 11Buy19.481172,279194,071May 11 05:36 PM
Baker Brothers Life Sciences CDirectorMay 11Buy19.4851,7101,007,2943,629,658May 11 05:29 PM
14159 capital (GP), LLCDirectorMay 11Buy19.481,44028,05198,152May 11 05:24 PM
Scott Randal WExecutive ChairmanMay 11Sale19.516,000117,0861,952,646May 12 08:24 PM
14159 capital (GP), LLCDirectorMay 08Buy19.6781916,11096,712May 11 05:24 PM
Baker Brothers Life Sciences CDirectorMay 08Buy19.6729,431578,9283,577,948May 11 05:29 PM
Baker / Tisch Capital (GP), LLDirectorMay 08Buy19.67671,318193,954May 11 05:36 PM
Baker Bros. Capital (GP), LLCDirectorMay 08Buy19.6719374194,047May 11 05:44 PM
Baker JoffreChief Scientific OfficerMay 08Sale19.724,62991,289187,152May 11 07:50 PM
Baker Brothers Life Sciences CDirectorMay 07Buy19.5456,3251,100,5663,548,517May 11 05:29 PM
14159 capital (GP), LLCDirectorMay 07Buy19.541,56830,63895,893May 11 05:24 PM
Baker Bros. Capital (GP), LLCDirectorMay 07Buy19.5436703194,028May 11 05:44 PM
Baker / Tisch Capital (GP), LLDirectorMay 07Buy19.541282,501193,887May 11 05:36 PM
Scott Randal WExecutive ChairmanApr 14Sale25.126,000150,7441,958,646Apr 15 07:07 PM
Scott Randal WExecutive ChairmanApr 13Sale25.816,000154,8531,964,646Apr 15 07:07 PM
Baker JoffreChief Scientific OfficerApr 01Sale25.274,629116,975191,781Apr 03 05:28 PM
Scott Randal WExecutive ChairmanMar 11Sale19.436,000116,5801,970,646Mar 12 09:33 PM
Scott Randal WExecutive ChairmanMar 10Sale19.376,000116,2201,976,646Mar 12 09:33 PM
Baker JoffreChief Scientific OfficerMar 03Sale19.134,62988,547196,410Mar 06 09:05 AM
Cole G BradleyCOO & CFOFeb 17Option Exercise1.335,0006,6508,000Feb 18 08:08 PM
Cole G BradleyCOO & CFOFeb 17Sale21.525,000107,6053,000Feb 18 08:08 PM
Baker JoffreChief Scientific OfficerFeb 12Sale20.604,62995,33522,226Feb 13 08:15 PM
Scott Randal WExecutive ChairmanFeb 11Sale20.876,000125,2491,982,646Feb 12 06:06 PM
Scott Randal WExecutive ChairmanFeb 10Sale20.836,000124,9891,988,646Feb 12 06:06 PM
Baker JoffreChief Scientific OfficerJan 12Sale19.414,62989,86026,855Jan 14 09:19 PM
open in yahoo | open in reuters | open in google